Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.43 |
| ▸ | KDM4A | O75164 | 2/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.43 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.43 |
| ▸ | TET3 | O43151 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1603824 | 1.00 | LMNA (0.53) | LMNAMAPTCYP3A4TSHRHIF1A | |
| Hydrochloric Acid SCHEMBL10391629 | 0.98 | LMNA (0.52) | LMNAMAPTCYP3A4TSHRHIF1A | |
| Tetrahydrothiophene SCHEMBL12468597 | 0.86 | LMNA (0.42) | LMNAMAPTCYP3A4TSHRHIF1A | |
| SCHEMBL11155839 | 0.86 | CYP3A4 (0.35) | LMNAMAPTCYP3A4TSHRHIF1A | |
| SCHEMBL10519491 | 0.83 | LMNA (0.50) | LMNAMAPTCYP3A4TSHRHIF1A | |
| SCHEMBL11396426 | 0.82 | MAPT (0.33) | LMNAMAPTCYP3A4TSHRHIF1A | |
| SCHEMBL11403455 | 0.82 | MAPT (0.34) | LMNAMAPTCYP3A4TSHRHIF1A | |
| SCHEMBL11395026 | 0.80 | MAPT (0.38) | LMNAMAPTCYP3A4TSHRHIF1A | |
| SCHEMBL27546132 | 0.80 | CYP3A4 (0.32) | LMNAMAPTCYP3A4TSHRHIF1A | |
| SCHEMBL27291811 | 0.79 | TSHR (0.38) | LMNAMAPTCYP3A4TSHRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107021952-A | A kind of different luminol derivative and its preparation method and application | 深圳市新产业生物医学工程股份有限公司 | 2017-08-08 | — | — | CN | claimed |
| WO-2025028636-A1 | DEGRADABLE CROSSLINKING AGENT | ナガセケムテックス株式会社 | 2025-02-06 | — | — | WO | disclosed |
| WO-2024195687-A1 | DEGRADABLE CROSSLINKING AGENT | ナガセケムテックス株式会社 | 2024-09-26 | — | — | WO | disclosed |
| WO-2024195685-A1 | DEGRADABLE CROSSLINKING AGENT | ナガセケムテックス株式会社 | 2024-09-26 | — | — | WO | disclosed |
| CN-116997701-A | Roof component | ＡＧＣ株式会社 | 2023-11-03 | — | — | CN | disclosed |
| US-20230291010-A1 | SOLID ELECTROLYTE, BATTERY, AND SOLID ELECTROLYTE MANUFACTURING METHOD | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2023-09-14 | — | — | US | disclosed |
| WO-2023162870-A1 | BLOCK ISOCYANATE COMPOSITION, COATING MATERIAL COMPOSITION AND COATING FILM | 旭化成株式会社 | 2023-08-31 | — | — | WO | disclosed |
| CN-116669811-A | Compositions and methods for enhancing visual function | 加利福尼亚大学董事会 | 2023-08-29 | — | — | CN | disclosed |
| CN-116569364-A | Solid electrolyte, battery, and method for producing solid electrolyte | 松下知识产权经营株式会社 | 2023-08-08 | — | — | CN | disclosed |
| US-20230201383-A1 | PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING | RIGSHOSPITALET (DK) | 2023-06-29 | — | — | US | disclosed |
| EP-1019364-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE | PHARMACIA & UPJOHN COMPANY (US) | 2000-07-19 | — | — | EP | disclosed |
| US-5985909-A | Cyclopropylindoles and their seco precursors, and their use as prodrugs | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1999-11-16 | — | — | US | disclosed |
| EP-0938474-A2 | CYCLOPROPYLINDOLE COMPOUNDS AND THEIR USE AS PRODRUGS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1999-09-01 | — | — | EP | disclosed |
| WO-1999011606-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE | PHARMACIA & UPJOHN COMPANY (US) | 1999-03-11 | — | — | WO | disclosed |
| EP-0850220-A1 | CYCLOPROPYLINDOLES AND THEIR SECO PRECURSORS, AND THEIR USE AS PRODRUGS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) | 1998-07-01 | — | — | EP | disclosed |
| WO-1998011101-A2 | CONDENSED N-ACLYINDOLES AS ANTITUMOR AGENTS | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1998-03-19 | — | — | WO | disclosed |
| WO-1997007097-A1 | CYCLOPROPYLINDOLES AND THEIR SECO PRECURSORS, AND THEIR USE AS PRODRUGS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) | 1997-02-27 | — | — | WO | disclosed |
| US-4173693-A | PHASE-TRANSFER CATALYSTS | THE DOW CHEMICAL COMPANY (US) | 1979-11-06 | — | — | US | disclosed |
| US-4092424-A | PLEUROMUTILIN DERIVATIVES | BIOCHEMIE GES.M.B.H. (OE) | 1978-05-30 | — | — | US | disclosed |
| US-3949079-A | PLEUROMUTILIN; BACTERICIDES IN ANIMAL FEEDS | BIOCHEMIE GES.M.B.H. (OE) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201383-A1 | PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING | KLK3, FOLH1, PSMA7 | LMNA 4313/4885MAPT 1474/4885CYP3A4 3951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.